Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
What is the expected demand growth for GLP-1 Companion Products in the global market between 2026 and 2036
Starting a prescription-based weight loss journey can feel like a big step
Dipeptidyl Peptidase 4 (DPP-4) Inhibitors are the fastest growing segment in the Glucagon-like Peptide 1 (GLP-1) market, attributed to their convenience and ease of use for patients who prefer oral medications or have aversions to injections
Injection of exendin-4 into the LH reduced lever-pressing behavior, while injection of exendin-9, a GLP-1R antagonist, increased food reinforcement
US$ 28.15
US$ 23.52
US$ 21.38
US$ 28.47
US$ 23.78
US$ 22.04
US$ 22.70
US$ 25.89
US$ 25.58
US$ 25.56
US$ 27.94
